tetano
Editor, Senior Moderator
Lea Caduff[SUP]1[/SUP] 
, David Dreifuss[SUP]2,3[/SUP] , Tobias Schindler[SUP]4,5[/SUP] , Alexander J Devaux[SUP]1[/SUP] , Pravin Ganesanandamoorthy[SUP]1[/SUP] , Anina Kull[SUP]1[/SUP] , Elyse Stachler[SUP]1[/SUP] , Xavier Fernandez-Cassi[SUP]6[/SUP] , Niko Beerenwinkel[SUP]2,3[/SUP] , Tamar Kohn[SUP]6[/SUP] , Christoph Ort[SUP]1[/SUP] , Timothy R Julian[SUP]1,4,5[/SUP]
Background
Throughout the COVID-19 pandemic, SARS-CoV-2 genetic variants of concern (VOCs) have repeatedly and independently arisen. VOCs are characterised by increased transmissibility, increased virulence or reduced neutralisation by antibodies obtained from prior infection or vaccination. Tracking the introduction and transmission of VOCs relies on sequencing, typically whole genome sequencing of clinical samples. Wastewater surveillance is increasingly used to track the introduction and spread of SARS-CoV-2 variants through sequencing approaches.
Aim
Here, we adapt and apply a rapid, high-throughput method for detection and quantification of the relative frequency of two deletions characteristic of the Alpha, Beta, and Gamma VOCs in wastewater.
Methods
We developed drop-off RT-dPCR assays and an associated statistical approach implemented in the R package WWdPCR to analyse temporal dynamics of SARS-CoV-2 signature mutations (spike Δ69–70 and ORF1a Δ3675–3677) in wastewater and quantify transmission fitness advantage of the Alpha VOC.
Results
Based on analysis of Zurich wastewater samples, the estimated transmission fitness advantage of SARS-CoV-2 Alpha based on the spike Δ69–70 was 0.34 (95% confidence interval (CI): 0.30–0.39) and based on ORF1a Δ3675–3677 was 0.53 (95% CI: 0.49–0.57), aligning with the transmission fitness advantage of Alpha estimated by clinical sample sequencing in the surrounding canton of 0.49 (95% CI: 0.38–0.61).
Conclusion
Digital PCR assays targeting signature mutations in wastewater offer near real-time monitoring of SARS-CoV-2 VOCs and potentially earlier detection and inference on transmission fitness advantage than clinical sequencing.
full article
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.10.2100806#html_fulltext
, David Dreifuss[SUP]2,3[/SUP] , Tobias Schindler[SUP]4,5[/SUP] , Alexander J Devaux[SUP]1[/SUP] , Pravin Ganesanandamoorthy[SUP]1[/SUP] , Anina Kull[SUP]1[/SUP] , Elyse Stachler[SUP]1[/SUP] , Xavier Fernandez-Cassi[SUP]6[/SUP] , Niko Beerenwinkel[SUP]2,3[/SUP] , Tamar Kohn[SUP]6[/SUP] , Christoph Ort[SUP]1[/SUP] , Timothy R Julian[SUP]1,4,5[/SUP]Background
Throughout the COVID-19 pandemic, SARS-CoV-2 genetic variants of concern (VOCs) have repeatedly and independently arisen. VOCs are characterised by increased transmissibility, increased virulence or reduced neutralisation by antibodies obtained from prior infection or vaccination. Tracking the introduction and transmission of VOCs relies on sequencing, typically whole genome sequencing of clinical samples. Wastewater surveillance is increasingly used to track the introduction and spread of SARS-CoV-2 variants through sequencing approaches.
Aim
Here, we adapt and apply a rapid, high-throughput method for detection and quantification of the relative frequency of two deletions characteristic of the Alpha, Beta, and Gamma VOCs in wastewater.
Methods
We developed drop-off RT-dPCR assays and an associated statistical approach implemented in the R package WWdPCR to analyse temporal dynamics of SARS-CoV-2 signature mutations (spike Δ69–70 and ORF1a Δ3675–3677) in wastewater and quantify transmission fitness advantage of the Alpha VOC.
Results
Based on analysis of Zurich wastewater samples, the estimated transmission fitness advantage of SARS-CoV-2 Alpha based on the spike Δ69–70 was 0.34 (95% confidence interval (CI): 0.30–0.39) and based on ORF1a Δ3675–3677 was 0.53 (95% CI: 0.49–0.57), aligning with the transmission fitness advantage of Alpha estimated by clinical sample sequencing in the surrounding canton of 0.49 (95% CI: 0.38–0.61).
Conclusion
Digital PCR assays targeting signature mutations in wastewater offer near real-time monitoring of SARS-CoV-2 VOCs and potentially earlier detection and inference on transmission fitness advantage than clinical sequencing.
full article
https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.10.2100806#html_fulltext
